ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Amarantus Bioscience Holdings Inc (CE)

Amarantus Bioscience Holdings Inc (CE) (AMBS)

0,000001
0,00
( 0,00% )
Mis à jour : 01:00:00

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
0,000001
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
334
0,000001 Fourchette du Jour 0,000001
0,000001 Plage de 52 semaines 0,0401
Cap du marché
Clôture Veille
0,000001
Ouverture
0,000001
Dernière Transaction
334
@
1.0E-6
Dernière heure de transaction
15:30:05
Volume financier
US$ 0
VWAP
0,000001
Volume moyen (3 m)
123 144
Actions en circulation
68 272 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
0,00
Bénéfice par action (BPA)
-0,07
Chiffre d'affairess
95k
Bénéfice net
-4,76M

À propos de Amarantus Bioscience Holdings Inc (CE)

Amarantus Bioscience Holdings (AMBS) is a biotechnology company developing treatments and diagnostics for diseases in the areas of neurology, regenerative medicine and orphan diseases through its subsidiaries. AMBS acquired the rights to the Engineered Skin Substitute program (ESS), a regenerative m... Amarantus Bioscience Holdings (AMBS) is a biotechnology company developing treatments and diagnostics for diseases in the areas of neurology, regenerative medicine and orphan diseases through its subsidiaries. AMBS acquired the rights to the Engineered Skin Substitute program (ESS), a regenerative medicine-based approach for treating severe burns with full-thickness autologous skin grown in tissue culture that is being pursued by AMBS' wholly-owned subsidiary Cutanogen Corporation. AMBS' wholly-owned subsidiary MANF Therapeutics, Inc. owns key intellectual property rights and licenses from a number of prominent universities related to the development of the therapeutic protein known as mesencephalic astrocyte-derived neurotrophic factor ("MANF"). MANF Therapeutics, Inc. is developing MANF-based products as treatments for brain and ophthalmic disorders. MANF was discovered by the Company's Chief Scientific Officer John Commissiong, PhD. Dr. Commissiong discovered MANF from AMBS' proprietary discovery engine PhenoGuard. AMBS sold subsidiary Breakthrough Diagnostics to Todos Medical Ltd. in July of 2020. The Company also owns 51% of hemp/CBD company Hempori. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Carson City, Nevada, USA
Fondé
-
Amarantus Bioscience Holdings Inc (CE) est coté dans le secteur Pharmaceutical Preparations de la OTCMarkets avec le ticker AMBS. Le dernier cours de clôture d'Amarantus Bioscience (CE) était de US$0,00. Au cours de la dernière année, les actions de Amarantus Bioscience (CE) ont été négociées dans une fourchette de prix de US$ 0,000001 à US$ 0,0401.

Amarantus Bioscience (CE) compte actuellement 68 272 000 actions en circulation. La capitalisation boursière d'Amarantus Bioscience (CE) est de US$68,27 . Amarantus Bioscience (CE) a un ratio cours/bénéfice (ratio PE) de 0.00.

AMBS Dernières nouvelles

Todos Medical Expands Extraction Reagent and ANDiS 350 Extraction Automation Capacity to Support COVID-19 Testing in the USA

Full US use of ANDiS 350 extraction systems would increase US daily testing capacity by 25% 3D Med extraction capacity increased by 1,000,000 kits per week Extraction reagent and automation...

Amarantus Acquires Majority Interest in CBD Wellness Company Hempori

Amarantus Acquires Majority Interest in CBD Wellness Company Hempori    Strong customer retention at both stores in Dallas, TX with growing online presence  Focus...

Amarantus Provides 2019 Roadmap

  Amarantus Provides 2019 Roadmap   New York, NY -- January 7, 2019 -- InvestorsHub NewsWire -- Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the...

Coeptis Pharma Enters into Agreement to Acquire Elto Pharma

    Coeptis Pharma Enters into Agreement to Acquire Elto Pharma   New York, NY and Wexford, PA -- November 28, 2018 -- InvestorsHub NewsWire -- Coeptis...

Amarantus Provides Corporate Update

  Amarantus Provides Corporate Update   New York, NY -- July 20, 2018 -- InvestorsHub NewsWire -- Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the...

MANF Therapeutics Announces Positive MANF Pre-Clinical Data in Alpha-Synuclein Model of Parkinson's Disease Published in

  MANF Therapeutics Announces Positive MANF Pre-Clinical Data in Alpha-Synuclein Model of Parkinson's Disease Published in Peer-Reviewed Journal Experimental...

MANF Therapeutics Announces Independent Publication of Positive Data for MANF in Traumatic Brain Injury Animal Model

  MANF Therapeutics Announces Independent Publication of Positive Data for MANF in Traumatic Brain Injury Animal Model New York, NY -- June 11, 2018 -- InvestorsHub NewsWire...

Amarantus Provides Update on Elto Pharma Capital Formation Plan

  Amarantus Provides Update on Elto Pharma Capital Formation Plan   New York, NY -- June 07, 2018 -- InvestorsHub NewsWire --  Amarantus Bioscience Holdings, Inc...

MANF Therapeutics Announces Publication of Positive Data for MANF in Stroke Animal Model in AAAS Journal Science Advances

  MANF Therapeutics Announces Publication of Positive Data for MANF in Stroke Animal Model in AAAS Journal Science Advances   New York, NY USA -- June 05, 2018...

Amarantus Exercises Exclusive Option with Leipzig University for Alzheimer's Blood Diagnostic "LymPro Test 2.0"

Amarantus Exercises Exclusive Option with Leipzig University for Alzheimer's Blood Diagnostic "LymPro Test 2.0"   Scope of exercised Exclusive Option Agreement...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1001.0E-61.0E-61.0E-61341.0E-6CS
4001.0E-61.0E-61.0E-61341.0E-6CS
12-0.040099-99.99750623440.04010.04011.0E-61231440.00020039CS
26-9.9E-5-990.00010.04011.0E-6857780.00016295CS
52-0.000699-99.85714285710.00070.04011.0E-63115320.00049042CS
156-0.012499-99.9920.01250.04011.0E-614944650.00270048CS
260-0.013099-99.99236641220.01310.04011.0E-614586290.005833CS

AMBS - Frequently Asked Questions (FAQ)

What is the current Amarantus Bioscience (CE) share price?
The current share price of Amarantus Bioscience (CE) is US$ 0,000001
How many Amarantus Bioscience (CE) shares are in issue?
Amarantus Bioscience (CE) has 68 272 000 shares in issue
What is the market cap of Amarantus Bioscience (CE)?
The market capitalisation of Amarantus Bioscience (CE) is USD 68,27
What is the 1 year trading range for Amarantus Bioscience (CE) share price?
Amarantus Bioscience (CE) has traded in the range of US$ 0,000001 to US$ 0,0401 during the past year
What is the cash to sales ratio of Amarantus Bioscience (CE)?
The cash to sales ratio of Amarantus Bioscience (CE) is 0
What is the reporting currency for Amarantus Bioscience (CE)?
Amarantus Bioscience (CE) reports financial results in USD
What is the latest annual turnover for Amarantus Bioscience (CE)?
The latest annual turnover of Amarantus Bioscience (CE) is USD 95k
What is the latest annual profit for Amarantus Bioscience (CE)?
The latest annual profit of Amarantus Bioscience (CE) is USD -4,76M
What is the registered address of Amarantus Bioscience (CE)?
The registered address for Amarantus Bioscience (CE) is 701 S CARSON STREET, SUITE 200, CARSON CITY, NEVADA, 89701
What is the Amarantus Bioscience (CE) website address?
The website address for Amarantus Bioscience (CE) is www.amarantus.com
Which industry sector does Amarantus Bioscience (CE) operate in?
Amarantus Bioscience (CE) operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
GNSPFGenusPlus Group Ltd (PK)
US$ 1,60
(319 900,00%)
1 000
UNDRUnderSea Recovery Corporation (CE)
US$ 0,0009
(89 900,00%)
25k
HLLPFHello Pal International Inc (CE)
US$ 0,0002
(19 900,00%)
33,17k
SVSNStereo Vision Entertainment Inc (CE)
US$ 0,0002
(19 900,00%)
500
WRCDFWirecard AG (CE)
US$ 0,01
(9 900,00%)
2,25k
RAASYCloopen Group Holding Limited (CE)
US$ 0,000001
(-100,00%)
588
MEDEMEdIES (CE)
US$ 0,000001
(-100,00%)
1,95k
ELIQQElectriq Power Holdings Inc (CE)
US$ 0,000001
(-99,98%)
407,63k
EWGFFEat Well Investment Group Inc (CE)
US$ 0,00001
(-99,97%)
17,2k
NEPTFNeptune Wellness Solutions Inc (CE)
US$ 0,000001
(-99,90%)
40,52k
RONNRonn Motor Group Inc (PK)
US$ 0,0006
(50,00%)
359,06M
PHILPHI Group Inc (PK)
US$ 0,0004
(-20,00%)
264,54M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0,0001
(0,00%)
232,93M
HMBLHUMBL Inc (PK)
US$ 0,00075
(-11,76%)
122,79M
GRLTGrillit Inc (PK)
US$ 0,0009
(0,00%)
117,94M
Aucune Discussion Trouvée
Ajouter une Discussion